Brief: ORIC Pharmaceuticals Reports Fourth Quarter Loss Per Share $0.52

ORIC Pharmaceuticals

16/03/2023 22:49

March 16 (Reuters) - ORIC Pharmaceuticals Inc  ORIC.O :
    * ORIC PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND OPERATIONAL UPDATES
    * CASH AND INVESTMENTS OF $228.2 MILLION EXPECTED TO FUND
OPERATING PLAN INTO FIRST HALF OF 2025
    * CASH, CASH EQUIVALENTS AND INVESTMENTS TOTALED $228.2
MILLION AS
OF DECEMBER 31, 2022
    * QTRLY LOSS PER SHARE $0.52
    * Q4 EARNINGS PER SHARE VIEW $-0.54, REVENUE VIEW $0.00 --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX72Zj4w 
Further company coverage:  ORIC.O 

 ((Reuters.Briefs@thomsonreuters.com;))